229 structural-engineering-"https:"-"https:"-"https:"-"https:"-"https:"-"https:"-"UCL" positions at Nature Careers in United States
Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
the Invisible in Protein Kinases " is an inter-disciplinary project in the Department of Structural Biology and is supported by US $50 million in institutional funding. This large-scale project leverages ultra
-
molecular biology and genome‑engineering projects. In this role, you will contribute to genome‑editing workflows and other core services, with a primary focus on strengthening the mutation‑detection pipeline
-
, liposomes, and other engineered delivery systems for oncology and regenerative medicine applications. Research Environment: Our lab integrates chemical biology, biomaterials engineering, and translational
-
access to cutting-edge institutional shared resources. Successful candidates should have a PhD, MD, or MD-PhD in Chemistry, Chemical Biology, Chemical/Biological Engineering or related academic disciplines
-
, Chemical/Biological Engineering or related academic disciplines. St. Jude is an Equal Opportunity Employer No Search Firms St. Jude Children's Research Hospital does not accept unsolicited assistance from
-
. Thinks long-term in building and executing metrics-driven plans and stretch goals for St. Jude. Builds structures and processes with clear lines of authority and accountability so teams know what
-
to meet the goals and objectives of the department and institution. Maintains regular and predictable attendance. Minimum Education and/or Training: Bachelor's degree in computer science, engineering
-
Job Description The Protein Technologies Center (PTC) comprises a team of 13 scientists within the Department of Structural Biology, specializing in protein biochemistry, molecular biology
-
performance. Collaborate closely with architects, engineers, and construction teams to ensure data center designs meet operational requirements, industry standards (e.g., Uptime Institute tiers), and regulatory
-
genetic screen (e.g., metabolic pathway, mitochondria structure) 2) Understanding the role of innate immunity during leukemogenesis as well as disease relapse in order to design novel inhibitors